| Particulars |
| Company Name |
Natco Pharma Ltd |
Year End |
202603 |
| Full Year |
| Equity (Rs Cr.) |
39.23 |
B.V. Rs |
501.20 |
| Sales Rs Cr. |
3,594.60 |
NP Rs Cr. |
1,299.73 |
| NP Var% |
-26.00 |
Div% |
250.00 |
| CPS Rs |
75.90 |
EPS Rs |
66.30 |
| Traded Value(Rs Lakhs) |
292.52 |
52 Week High |
1,216.00 |
| 52 Week Low |
774.00 |
Price BSE |
786.00 |
| Price NSE |
785.00 |
Market Capital(Rs Cr.) |
15,408.99 |
| P/C Ratio |
10.40 |
P/E Ratio |
11.90 |
| Price Vs.BV |
1.57 |
|
| Latest Quarter |
| Year End |
202606 |
Sales Rs Cr. |
596.60 |
| NP Rs Cr. |
74.60 |
NP Var % |
-84.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
4,119.60 |
| OPM |
54.49 |
NP |
1,838.50 |
| NP Var% |
-46.85 |
EPS |
45.47 |
| PE |
17.28 |
|
|